Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial

BACKGROUND There is concern that recommending protein-enriched meal replacements as part of a weight management program could lead to changes in biomarkers of liver or renal function and reductions in bone density. This study was designed as a placebo-controlled clinical trial utilizing two isocaloric meal plans utilizing either a high protein-enriched (HP) or a standard protein (SP) meal repla...

متن کامل

Meal replacements, reduced energy density eating and weight loss maintenance in primary care patients: A randomized controlled trial

OBJECTIVE To compare the presence or absence of meal replacements (MRs) and an energy density (ED) intervention to facilitate weight loss maintenance. DESIGN AND METHODS A total of 238 overweight primary care patients (mean body mass index = 39.5 kg/m(2) ) began the study; 132 completed the 12-week weight loss phase. Participants were randomly assigned to one of four maintenance conditions fo...

متن کامل

Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trial.

BACKGROUND Soy foods contain several components (isoflavones and amino acids) that potentially affect bone. Few long-term, large clinical trials of soy as a means of improving bone mineral density (BMD) in late postmenopausal women have been conducted. OBJECTIVE Our goal was to evaluate the long-term effect of dietary soy protein and/or soy isoflavone consumption on skeletal health in late po...

متن کامل

Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial

BACKGROUND Tiludronate and clodronate are FDA-approved bisphosphonate drug therapies for navicular disease in horses. Although clinical studies have determined their ability to reduce lameness associated with skeletal disorders in horses, data regarding the effect on bone structure and remodeling is lacking. Additionally, due to off-label use of these drugs in young performance horses, effects ...

متن کامل

How to ... do a randomized controlled trial.

In this section of the series on orthodontic research we intend to give a brief outline of how to carry out a randomized controlled trial (RCT). The RCT is one of the most simple and powerful research tools in which people are allocated at random to receive one of several clinical interventions. We hope that this will not only provide information to anyone who is aiming to carry out research of...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Nutrition Journal

سال: 2010

ISSN: 1475-2891

DOI: 10.1186/1475-2891-9-72